摘要 |
This invention concerns the compounds of Formula (I), the pharmaceutically acceptable salts and stereoisomeric forms thereof, and also the N-oxide forms thereof. In said formula, R<1> and R<2> each independently are hydrogen; C1-6 alkyl; C1-6 alkylcarbonyl; trihalomethylcarbonyl; C1-6 alkyl substituted with hydroxy, C1-6alkyloxy, carboxyl, C1-6 alkylcarbonyloxy, C1-6 alkyloxycarbonyl or aryl; or R<1> and R<2> taken together with the nitrogen atom to which they are attached may form a morpholinyl ring or an optionally substituted heterocycle; R<3> to R<10> each independently are hydrogen, halo, cyano, hydroxy, trifluoromethyl, trifluormethoxy, carboxyl, nitro, amino, mono-or di(C1-6alkyl)amino, C1-6 alkylcarbonylamino, aminosulfonyl, mono-or di(C1-6alkyl)- aminosulfonyl, C1-6 alkyl, C1-6 alkyloxy, C1-6alkylcarbonyl, C1-6 alkyloxycarbonyl; R<11> is hydrogen, C1-6alkyl, or trifluoromethyl; R<12> is hydrogen, C1-6 alkyl, cyano, or trifluorotmethyl; n is zero to 6; and X is O, S, S(=O) or S(=O)2. The compounds of formula (I)may be used as therapeutic agents in the treatment or the prevention of CNS disorders, cardiovascular disorders or gastrointestinal disorders. |
申请人 |
JANSSEN PHARMACEUTICA N.V.;FERNANDEZ-GADEA, FRANCISCO JAVIER;SIPIDO, VICTOR, KAREL;ANDRES-GIL, JOSE IGNACIO;MEERT, THEO, FRANS |
发明人 |
FERNANDEZ-GADEA, FRANCISCO JAVIER;SIPIDO, VICTOR, KAREL;ANDRES-GIL, JOSE IGNACIO;MEERT, THEO, FRANS |